Phase III Cat-PAD Study
Public ClinicalTrials.gov record NCT01620762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomised, Placebo-Controlled Multi-Centre Field Study to Assess the Efficacy and Safety of Cat-PAD Peptide Immunotherapy in Cat Allergic Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the treatment effect of two treatment regimens of Cat-PAD vs placebo and to evaluates the treatment effect of Cat-PAD on symptoms, rescue medication usage and Quality of Life.
Study identification
- NCT ID
- NCT01620762
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,408 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2012 (Type not available)
- Primary completion
- Jun 2016 (Actual)
- Completion
- Not listed
- Last update posted
- Jun 15, 2018
Started 2012
United States locations
- U.S. sites
- 52
- U.S. states
- 27
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Rolling Hills Estates | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Wheat Ridge | Colorado | — | — |
| Not listed | Eagle | Idaho | — | — |
| Not listed | Meridian | Idaho | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Evanston | Illinois | — | — |
| Not listed | Forrest | Illinois | — | — |
| Not listed | Normal | Illinois | — | — |
| Not listed | Iowa City | Iowa | — | — |
| Not listed | Overland Park | Kansas | — | — |
| Not listed | Bangor | Maine | — | — |
| Not listed | Brockton | Massachusetts | — | — |
| Not listed | Ypsilanti | Michigan | — | — |
| Not listed | Minneapolis | Minnesota | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Bozeman | Montana | — | — |
| Not listed | Missoula | Montana | — | — |
| Not listed | Bellevue | Nebraska | — | — |
| Not listed | Fremont | Nebraska | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Ocean Township | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Corning | New York | — | — |
| Not listed | Newburgh | New York | — | — |
| Not listed | Fargo | North Dakota | — | — |
| Not listed | Minot | North Dakota | — | — |
| Not listed | Canton | Ohio | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Middleburg Heights | Ohio | — | — |
| Not listed | Sylvania | Ohio | — | — |
| Not listed | Toledo | Ohio | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Lake Oswego | Oregon | — | — |
| Not listed | Medford | Oregon | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Blue Bell | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Germantown | Tennessee | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Draper | Utah | — | — |
| Not listed | Glen Allen | Virginia | — | — |
| Not listed | South Burlington | Virginia | — | — |
| Not listed | Warrenton | Virginia | — | — |
| Not listed | Spokane | Washington | — | — |
| Not listed | Greenfield | Wisconsin | — | — |
| Not listed | Madison | Wisconsin | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01620762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 15, 2018 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01620762 live on ClinicalTrials.gov.